Home > Health & Beauty > Biotechnology
Biotechnology
February 10, 2012 23:00
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) will move the timing of its conference call with investors to start at 1:30 p.m. PST (4:30 p.m. EST) on February 14, 2012.
February 10, 2012 21:42
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 fourth quarter financial results before the opening of the market on February 15, 2012. The Company will host a conference call at 8:00 a.m., Eastern Time on February 15, 2012 to discuss its fo...
February 10, 2012 21:38
ZURICH & AMSTERDAM--(BUSINESS WIRE)--Investment community to come out in full force at BIO-Europe Spring® 2012
February 10, 2012 20:40
--(BUSINESS WIRE)--Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets.
February 10, 2012 20:30
SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Leerink Swann Global Healthcare Conference. The live presentation will occur at 10:30 a.m. Pacific Time (1:30 p.m. Eastern Time) on Thur...
February 10, 2012 20:03
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme today announced its participation in the Leerink Swann 2012 Global Healthcare Conference, the Citi 2012 Global Healthcare Conference, and the Oncology Partnering & Deal Making Conference.
